Jean-Sébastien Delisle

Associate-professor

Université de Montréal

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jean-Sébastien Delisle is an Associate Professor at Université de Montréal, Canada. His research primarily focuses on hematopoietic cell transplantation and cellular therapies, particularly in the context of B-cell lymphomas and multiple myeloma. Recent publications include studies on CAR-T efficacy, real-world outcomes of stem cell transplants, and the regulation of cellular senescence in T cells.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Krystel Vincent

CANADA

View details

Alejandro Garcia-Horton

McMaster University

CANADA

View details

Jean Roy

Full professor

Université de Montréal

CANADA

View details

Jonathan Bramson

McMaster University

CANADA

View details

Sergio Crespo-Garcia

Assistant Professor

Université de Montréal

CANADA

View details

Mathias Castonguay

Université de Montréal

CANADA

View details

Guy Sauvageau

Affiliated professor

Université de Montréal

CANADA

View details

Gregory Ehx

University of Liege

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jean-Sébastien Delisle

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center

Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience

Abstracts of the Cell Therapy Transplant Canada 2023 Annual Conference

A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant

Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective

Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study

Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma

Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference

Myeloid‐resident neuropilin‐1 promotes choroidal neovascularization while mitigating inflammation

Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes.

p16<sup>INK4a</sup> Regulates Cellular Senescence in PD-1-Expressing Human T Cells.

CD5 levels define functionally heterogeneous populations of naïve human CD4<sup>+</sup> T cells.

T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies

Collaborators (8)

Krystel Vincent

Alejandro Garcia-Horton

Jean Roy

Jonathan Bramson

Sergio Crespo-Garcia

Mathias Castonguay

Guy Sauvageau

Gregory Ehx

Make your next move.